Health secretary Wes Streeting is considering expanding the existing schedule to age groups beyond infants, such as teenagers ...

The FDA has issued a CRL to Aldeyra Therapeutics for its new drug application (NDA) of reproxalap to treat dry eye disease.

R1 Therapeutics has raised $77.5m in an oversubscribed Series A funding to advance AP306 for hyperphosphatemia in CKD ...

In a recent article, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T cells directly within ...

At Advanced Therapies, investors noted that early planning, adaptability and building trust will help a biotech startup ...

The court ruling reverses several changes by the CDC’s vaccine panel to childhood immunisation recommendations.

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.

Sentynl Therapeutics has signed an agreement with PRG S&T to license Progerinin, an investigational molecule intended to ...

While the FDA can legally make prescription drugs OTC, legal expert Heidi Gertner notes that this wider shift depends on ...

The FDA has accepted for review Sun Pharmaceutical’s sBLA submitted for Ilumya to treat adults with active psoriatic ...

Bavarian Nordic has signed a manufacturing agreement with SII, expanding its strategic partnership through a contract for its ...